http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2708616-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e01290e9d1b84b4ddf45d01f66c58d8c |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y40-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y40-00 |
filingDate | 2019-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e892fad0d816cf84f9ed2005f34d522c |
publicationDate | 2019-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2708616-C1 |
titleOfInvention | Method of producing virkon-s nanocapsules in sodium alginate |
abstract | FIELD: nanotechnology; veterinary science.SUBSTANCE: invention relates to nanotechnology, veterinary science. Method of obtaining Virkon-S nanocapsules in sodium alginate is characterized by that Virkon-S is added in portions to a suspension of sodium alginate in hexane in presence of 0.01 g of preparation E472c as a surfactant while stirring at 700 rpm, then 6 ml of fluorobenzene is added, the formed suspension is filtered and dried at room temperature, wherein the weight ratio of core to polymer is 1:3, 1:1 or 1:2.EFFECT: disclosed is a method of producing Virkon-S nanocapsules.1 cl, 3 ex |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2780885-C1 |
priorityDate | 2019-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.